Prediction of regulatory networks in mouse abdominal wall

Gene

Volumn 469, Issue 1-2, 2010, Pages 1-8

  Eng, Diana ^a   Campbell, Adam ^a   Hilton, Traci ^a   Leid, Mark ^a   Gross, Michael K ^a   Kioussi, Chrissa ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Bioinformatics; Development; Gene expression analysis; Gene regulation; Homeobox; Pitx2

Indexed keywords

TRANSCRIPTION FACTOR PITX2; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

ABDOMINAL WALL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL GROWTH; CELL TRANSPORT; EMBRYO; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE REGULATORY NETWORK; GENE SEQUENCE; GENE TARGETING; HETEROZYGOSITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TRANSPORT; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; MORPHOGENESIS; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE;

ABDOMINAL WALL; ANIMALS; BINDING SITES; CONSERVED SEQUENCE; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; MICE; MODELS, GENETIC; MORPHOGENESIS; MULTIGENE FAMILY; PHENOTYPE; TRANSCRIPTION FACTORS;

MAMMALIA; MUS;

EID: 77957864703     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2010.08.008     Document Type: Article

References (61)

1. Ai X., Kitazawa T., Do A.T., Kusche-Gullberg M., Labosky P.A., Emerson C.P. SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development 2007, 134:3327-3338.
2. Amendt B.A., Sutherland L.B., Semina E.V., Russo A.F. The molecular basis of Rieger syndrome. Analysis of Pitx2 homeodomain protein activities. J. Biol. Chem. 1998, 273:20066-20072.
3. Bader B.L., Rayburn H., Crowley D., Hynes R.O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 1998, 95:507-519.
4. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
5. Brewer S., Williams T. Finally, a sense of closure? Animal models of human ventral body wall defects. Bioessays 2004, 26:1307-1321.
6. Brewer S., Williams T. Loss of AP-2alpha impacts multiple aspects of ventral body wall development and closure. Dev. Biol. 2004, 267:399-417.
7. Chang P.Y., Yeh M.L., Sheu J.C., Chen C.C. Experience with treatment of gastroschisis and omphalocele. J. Formos. Med. Assoc. 1992, 91:447-451.
8. Christ B., Jacob M., Jacob H.J. On the origin and development of the ventrolateral abdominal muscles in the avian embryo. An experimental and ultrastructural study. Anat Embryol (Berl) 1983, 166:87-101.
9. Cohen S., Funkelstein L., Livet J., Rougon G., Henderson C.E., Castellani V., Mann F. A semaphorin code defines subpopulations of spinal motor neurons during mouse development. Eur. J. Neurosci. 2005, 21:1767-1776.
10. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4.
11. Dietrich S., Abou-Rebyeh F., Brohmann H., Bladt F., Sonnenberg-Riethmacher E., Yamaai T., Lumsden A., Brand-Saberi B., Birchmeier C. The role of SF/HGF and c-Met in the development of skeletal muscle. Development 1999, 126:1621-1629.
12. Ebens A., Brose K., Leonardo E.D., Hanson M.G., Bladt F., Birchmeier C., Barres B.A., Tessier-Lavigne M. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 1996, 17:1157-1172.
13. El-Karef A., Yoshida T., Gabazza E.C., Nishioka T., Inada H., Sakakura T., Imanaka-Yoshida K. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J. Pathol. 2007, 211:86-94.
14. Fleming C.E., Saraiva M.J., Sousa M.M. Transthyretin enhances nerve regeneration. J. Neurochem. 2007, 103:831-839.
15. Gage P.J., Suh H., Camper S.A. Dosage requirement of Pitx2 for development of multiple organs. Development 1999, 126:4643-4651.
16. Hanasaki K., Yokota Y., Ishizaki J., Itoh T., Arita H. Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice. J. Biol. Chem. 1997, 272:32792-32797.
17. Hecht J., Seitz V., Urban M., Wagner F., Robinson P.N., Stiege A., Dieterich C., Kornak U., Wilkening U., Brieske N., et al. Detection of novel skeletogenesis target genes by comprehensive analysis of a Runx2(-/-) mouse model. Gene Expr. Patterns 2007, 7:102-112.
18. Hilton T., Gross M.K., Kioussi C. Pitx2-dependent occupancy by histone deacetylases is associated with T-box gene regulation in mammalian abdominal tissue. J. Biol. Chem. 2010, 285:11129-11142.
19. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
20. Jaworski D.M., Soloway P., Caterina J., Falls W.A. Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits. J. Neurobiol. 2006, 66:82-94.
21. Jin L., Long L., Green M.A., Spear B.T. The alpha-fetoprotein enhancer region activates the albumin and alpha-fetoprotein promoters during liver development. Dev. Biol. 2009, 336:294-300.
22. Katz L.A., Schultz R.E., Semina E.V., Torfs C.P., Krahn K.N., Murray J.C. Mutations in PITX2 may contribute to cases of omphalocele and VATER-like syndromes. Am. J. Med. Genet. A 2004, 130:277-283.
23. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002, 12:996-1006.
24. Kioussi C., Gross M.K. How to build transcriptional network models of mammalian pattern formation. PLoS ONE 2008, 3:e2179.
25. Kioussi C., Briata P., Baek S.H., Rose D.W., Hamblet N.S., Herman T., Ohgi K.A., Lin C., Gleiberman A., Wang J., et al. Identification of a Wnt/Dvl/beta-Catenin ->Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 2002, 111:673-685.
26. Kitamura K., Miura H., Miyagawa-Tomita S., Yanazawa M., Katoh-Fukui Y., Suzuki R., Ohuchi H., Suehiro A., Motegi Y., Nakahara Y., et al. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism. Development 1999, 126:5749-5758.
27. Kleffens M., Groffen C., Neck J.W., Vermeij-Keers C., Drop S.L. mRNA and protein localization of the IGF system during mouse embryonic development in areas with apoptosis. Growth Horm. IGF Res. 1999, 9:195-204.
28. Kwon G.S., Hadjantonakis A.K. Transthyretin mouse transgenes direct RFP expression or Cre-mediated recombination throughout the visceral endoderm. Genesis 2009, 47:447-455.
29. Langsdorf A., Do A.T., Kusche-Gullberg M., Emerson C.P., Ai X. Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev. Biol. 2007, 311:464-477.
30. LeClair E.E., Mui S.R., Huang A., Topczewska J.M., Topczewski J. Craniofacial skeletal defects of adult zebrafish Glypican 4 (knypek) mutants. Dev. Dyn. 2009, 238:2550-2563.
31. Levy E., Haltia M., Fernandez-Madrid I., Koivunen O., Ghiso J., Prelli F., Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J. Exp. Med. 1990, 172:1865-1867.
32. Lieberam I., Agalliu D., Nagasawa T., Ericson J., Jessell T.M. A Cxcl12-CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons. Neuron 2005, 47:667-679.
33. Lin X., Perrimon N. Developmental roles of heparan sulfate proteoglycans in Drosophila. Glycoconj. J. 2002, 19:363-368.
34. Lin C.R., Kioussi C., O'Connell S., Briata P., Szeto D., Liu F., Izpisua-Belmonte J.C., Rosenfeld M.G. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999, 401:279-282.
35. Longabaugh W.J., Davidson E.H., Bolouri H. Computational representation of developmental genetic regulatory networks. Dev. Biol. 2005, 283:1-16.
36. Lu M.F., Pressman C., Dyer R., Johnson R.L., Martin J.F. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature 1999, 401:276-278.
37. Maina F., Hilton M.C., Ponzetto C., Davies A.M., Klein R. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev. 1997, 11:3341-3350.
38. Makover A., Moriwaki H., Ramakrishnan R., Saraiva M.J., Blaner W.S., Goodman D.S. Plasma transthyretin. Tissue sites of degradation and turnover in the rat. J Biol Chem 1988, 263:8598-8603.
39. Maltby S., Hughes M.R., Zbytnuik L., Paulson R.F., McNagny K.M. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery. Exp. Hematol. 2009, 37:10-18.
40. Mejillano M.R., Kojima S., Applewhite D.A., Gertler F.B., Svitkina T.M., Borisy G.G. Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell 2004, 118:363-373.
41. Ogi H., Suzuki K., Ogino Y., Kamimura M., Miyado M., Ying X., Zhang Z., Shinohara M., Chen Y., Yamada G. Ventral abdominal wall dysmorphogenesis of Msx1/Msx2 double-mutant mice. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2005, 284:424-430.
42. Ong K., Horsfall W., Conway E.M., Schuh A.C. Early embryonic expression of murine coagulation system components. Thromb. Haemost. 2000, 84:1023-1030.
43. Oshima Y., Ouchi N., Sato K., Izumiya Y., Pimentel D.R., Walsh K. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 2008, 117:3099-3108.
44. Saraiva M.J. Transthyretin amyloidosis: a tale of weak interactions. FEBS Lett. 2001, 498:201-203.
45. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., Gherardi E., Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995, 373:699-702.
46. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-2504.
47. Shih H.P., Gross M.K., Kioussi C. Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch. Proc. Natl Acad. Sci. USA 2007, 104:5907-5912.
48. Silacci P., Mazzolai L., Gauci C., Stergiopulos N., Yin H.L., Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell. Mol. Life Sci. 2004, 61:2614-2623.
49. Soriano J.V., Pepper M.S., Nakamura T., Orci L., Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 1995, 108(Pt 2):413-430.
50. Spencer J.A., Hacker S.L., Davis E.C., Mecham R.P., Knutsen R.H., Li D.Y., Gerard R.D., Richardson J.A., Olson E.N., Yanagisawa H. Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc. Natl Acad. Sci. USA 2005, 102:2946-2951.
51. Suzuki K., Economides A., Yanagita M., Graf D., Yamada G. New horizons at the caudal embryos: coordinated urogenital/reproductive organ formation by growth factor signaling. Curr. Opin. Genet. Dev. 2009, 19:491-496.
52. Tiger C.F., Gullberg D. Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. Muscle Nerve 1997, 20:1515-1524.
53. Timpl R., Rohde H., Robey P.G., Rennard S.I., Foidart J.M., Martin G.R. Laminin-a glycoprotein from basement membranes. J. Biol. Chem. 1979, 254:9933-9937.
54. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 2001, 98:5116-5121.
55. Uehara Y., Minowa O., Mori C., Shiota K., Kuno J., Noda T., Kitamura N. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995, 373:702-705.
56. Verani R., Cappuccio I., Spinsanti P., Gradini R., Caruso A., Magnotti M.C., Motolese M., Nicoletti F., Melchiorri D. Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid. J. Neurochem. 2007, 100:242-250.
57. Veugelers M., Cat B.D., Muyldermans S.Y., Reekmans G., Delande N., Frints S., Legius E., Fryns J.P., Schrander-Stumpel C., Weidle B., et al. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum. Mol. Genet. 2000, 9:1321-1328.
58. Wilkinson L., Gilbert T., Kinna G., Ruta L.A., Pennisi D., Kett M., Little M.H. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development. J. Am. Soc. Nephrol. 2007, 18:1697-1708.
59. Wilson D.S., Sheng G., Jun S., Desplan C. Conservation and diversification in homeodomain-DNA interactions: a comparative genetic analysis. Proc. Natl Acad. Sci. USA 1996, 93:6886-6891.
60. Yang Y., Liu J., Mao H., Hu Y.A., Yan Y., Zhao C. The expression pattern of Follistatin-like 1 in mouse central nervous system development. Gene Expr. Patterns 2009, 9:532-540.
61. Ybot-Gonzalez P., Copp A.J., Greene N.D. Expression pattern of glypican-4 suggests multiple roles during mouse development. Dev. Dyn. 2005, 233:1013-1017.